Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression

doi:10.3748/wjg.v24.i16.1708

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9593)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

860

HTML

6467

Figures (1-3)

192

Tables (1-6)

229

Sum=7748

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

848

Download

997

Sum=1845

Apr 28, 2018 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (34)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Apr 28, 2018; 24(16): 1708-1724
Published online Apr 28, 2018. doi: 10.3748/wjg.v24.i16.1708

Full Size Figure Download Figure

Figure 3 Schematic representation indicating the role of preexisting hepatitis B virus reverse transcriptase mutations in liver disease progression and treatment outcomes. HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; ASC: Asymptomatic carriers; CHB: Chronic hepatitis B; HIV: Human immunodeficiency virus.

Citation: Choi YM, Lee SY, Kim BJ. Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression. World J Gastroenterol 2018; 24(16): 1708-1724
URL: https://www.wjgnet.com/1007-9327/full/v24/i16/1708.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i16.1708